323 related articles for article (PubMed ID: 2435857)
21. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
Keshgegian AA
Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
[TBL] [Abstract][Full Text] [Related]
22. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
[TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.
Perrot-Applanat M; Groyer-Picard MT; Lorenzo F; Jolivet A; Vu Hai MT; Pallud C; Spyratos F; Milgrom E
Cancer Res; 1987 May; 47(10):2652-61. PubMed ID: 2436753
[TBL] [Abstract][Full Text] [Related]
24. [Immunocytochemical staining of estrogen receptor in conventional formalin-fixed paraffin sections in human breast cancer].
Kawakami S; Kojima O; Uehara Y; Takahashi T
Nihon Geka Gakkai Zasshi; 1989 Jan; 90(1):102-7. PubMed ID: 2468075
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical assay for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tissue. Comparison with frozen section assay and with monoclonal antibody H222.
Miller RT; Hapke MR; Greene GL
Cancer; 1993 Jun; 71(11):3541-6. PubMed ID: 8490902
[TBL] [Abstract][Full Text] [Related]
26. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
[TBL] [Abstract][Full Text] [Related]
27. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
[TBL] [Abstract][Full Text] [Related]
29. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma.
Golouh R; Vrhovec I; Bracko M; Frković-Grazio S
Pathol Res Pract; 1997; 193(8):543-9. PubMed ID: 9406247
[TBL] [Abstract][Full Text] [Related]
30. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
Goussard J; Lechevrel C; Martin PM; Roussel G
Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
[TBL] [Abstract][Full Text] [Related]
31. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J
Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
[TBL] [Abstract][Full Text] [Related]
32. [Enzyme immunoassay and radioimmunoassay using monoclonal antibody for the determination of estrogen receptors in human breast cancer].
Ohnami S; Nakayama C; Ohnami S; Zeze F; Eto S
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3447-52. PubMed ID: 3539025
[TBL] [Abstract][Full Text] [Related]
33. Comparison of monoclonal immunocytochemical and immunoenzymatic methods for steroid receptor evaluation in breast cancer.
De Negri F; Campani D; Sarnelli R; Martini L; Gigliotti A; Bonacci R; Fabbri R; Squartini F; Pinchera A; Giani C
Am J Clin Pathol; 1991 Jul; 96(1):53-8. PubMed ID: 2069136
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
McClelland RA; Berger U; Miller LS; Powles TJ; Coombes RC
J Clin Oncol; 1986 Aug; 4(8):1171-6. PubMed ID: 2426418
[TBL] [Abstract][Full Text] [Related]
35. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
Noguchi S; Miyauchi K; Imaoka S; Koyama H; Iwanaga T
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: comparison with frozen sections and enzyme immunoassay.
Elias JM; Margiotta M; Sexton TR; Heimann A
J Cell Biochem Suppl; 1994; 19():126-33. PubMed ID: 7823584
[TBL] [Abstract][Full Text] [Related]
37. Immunoperoxidase localization of estrogen receptors in human brest carcinoma.
Garancis JC; Miller LS; Tomita JT; Tieu TM; Clowry LJ
Cancer Detect Prev; 1983; 6(1-2):235-9. PubMed ID: 6192919
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.
Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.
Charpin C; Martin PM; De Victor B; Lavaut MN; Habib MC; Andrac L; Toga M
Cancer Res; 1988 Mar; 48(6):1578-86. PubMed ID: 2449956
[TBL] [Abstract][Full Text] [Related]
40. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
